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Abstract
Background: b-Lapachone has antitumor and wound healing-promoting activities. To address the potential
influences of various chemicals on heart development of zebrafish embryos, we previously treated zebrafish
embryos with chemicals from a Sigma LOPAC1280™ library and found several chemicals including b-lapachone
that affected heart morphogenesis. In this study, we further evaluated the effects of b-lapachone on zebrafish
embryonic heart development.
Methods: Embryos were treated with b-lapachone or dimethyl sulfoxide (DMSO) at 24 or 48 hours post fertilization
(hpf) for 4 h at 28°C. Heart looping and valve development was analyzed by whole-mount in situ hybridization and
histological analysis. For fractional shortening and wall shear stress analyses, AB and Tg (gata1:DsRed) embryos were
recorded for their heart pumping and blood cell circulations via time-lapse fluorescence microscopy. Dextran
rhodamine dye injection into the tail reticular cells was used to analyze circulation. Reactive oxygen species (ROS)
was analyzed by incubating embryos in 5-(and 6-)-chloromethyl-2’,7’-dichloro-dihydrofluorescein diacetate (CM-
H2DCFDA) and recorded using fluorescence microscopy. o-Dianisidine (ODA) staining and whole mount in situ
hybridization were used to analyze erythrocytes. TUNEL assay was used to examine DNA fragmentation.
Results: We observed a linear arrangement of the ventricle and atrium, bradycardia arrhythmia, reduced fractional
shortening, circulation with a few or no erythrocytes, and pericardial edema in b-lapachone-treated 52-hpf
embryos. Abnormal expression patterns of cmlc2, nppa, BMP4, versican, and nfatc1, and histological analyses
showed defects in heart-looping and valve development of b-lapachone-treated embryos. ROS production was
observed in erythrocytes and DNA fragmentation was detected in both erythrocytes and endocardium of b-
lapachone-treated embryos. Reduction in wall shear stress was uncovered in b-lapachone-treated embryos. Co-
treatment with the NQO1 inhibitor, dicoumarol, or the calcium chelator, BAPTA-AM, rescued the erythrocyte-
deficiency in circulation and heart-looping defect phenotypes in b-lapachone-treated embryos. These results
suggest that the induction of apoptosis of endocardium and erythrocytes by b-lapachone is mediated through an
NQO1- and calcium-dependent pathway.
Conclusions: The novel finding of this study is that b-lapachone affects heart morphogenesis and function
through the induction of apoptosis of endocardium and erythrocytes. In addition, this study further demonstrates
the importance of endocardium and hemodynamic forces on heart morphogenesis and contractile performance.
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The heart is the first organ to form during vertebrate
embryonic development. An embryonic heart tube is
composed of outer myocardial and inner endocardial
layers. After chamber formation, cardiac valves are
formed from the endocardial cushion which is derived
from the endocardium located at the atrioventricular
boundary through an epithelial-to-mesenchymal transi-
tion [1]. The interaction between the myocardium and
endocardium was shown to be important for developing
a heart with normal functions. Bartman et al.d e m o n -
strated that reduced myocardial function can cause
defects in endocardial cushion development via both sih
and cfk zebrafish mutants associated with mutations in
cardiac troponin T and a sarcomeric actin [2]. Similarly,
a dysmorphic heart containing a compact ventricle and
enlarged atrium with reduced contractility was observed
in zebrafish cloche mutants with defects in the differen-
tiation of all endothelial cells [3].
Blood circulation occurs early in the linear heart tube
stage when diffuse oxygen is still sufficient to support
various physiological processes, suggesting that blood
circulation is required for heart morphogenesis [4]. The
proper formation of a heart with normal functions is
regulated by both a genetic program cascade and epige-
netic factors (e.g., blood fluidic shear stresses) [5-7].
Fluidic shear stress is the frictional force derived from
blood flow and plays an important role in embryonic
vascular remodeling and cardiac morphogenesis [7-10].
In both mlc2a-null mice and wea zebrafish mutants (i.e.,
either a mutation in the atrial myosin light chain 2 or
atrial myosin heavy chain gene), the mutation caused
enlarged atria as well as a compact ventricle with under-
developed trabeculae and a narrow lumen [11,12]. Since
only atrial cardiomyoctyes completely lack myofibril
organization, alteration of ventricle morphogenesis is
likely attributable to changes in hemodynamic forces.
Additionally, intracardiac fluidic forces were shown to
be one of the essential factors for heart-looping and
valve development in zebrafish embryos through block-
ing either the cardiac inflow or outflow by inserting
glass beads [8].
b-Lapachone (3,4-dihydro-2,2-dimethyl-2H- naphthol
[1,2-b] pyran-5,6-dione), a lipophilic ortho-naphthoqui-
none, was originally isolated from the lapacho tree
(Tabebuia avellanedae) of South America [13]. b-Lapa-
chone has antibacterial, antifungal, antiviral, anti-trypa-
nosomal, and antitumor activities [14-18]. In a number
of tumors (e.g., breast, colon, pancreatic, and lung can-
cers) with high expression levels of NAD(P)H:quinone
oxidoreductase (NQO1), b-lapachone activates a novel
apoptotic response [19-21]. In those tumors, NQO1 uti-
lizes NAD(P)H as an electron donor to catalyze the
two-electron reduction of b-lapachone to hydroquinone
and a semiquinone intermediate in a futile cycle, result-
ing in the formation of reactive oxygen species (ROS)
such as superoxide [21,22]. ROS can cause DNA
damage, hyperactivation of poly(ADP-ribose) polymerase
(PARP)-1 which depletes NAD
+ and ATP pools, that
respectively result in an increase of the intracellular
cytosolic Ca
2+ concentration, and activation of μ-calpain
cysteine protease activity [23-25]. Treatment with dicou-
marol (an NQO1 inhibitor) or BAPTA-AM (a Ca
2+ che-
lator) can inhibit cell death induced by b-lapachone
[26,27].
In addition to being a model organism for probing
vertebrate genetics and development, zebrafish have also
proven to be ideal for screening small-molecule libraries
to identify new therapeutic drugs [28,29]. To address
the potential influences of various chemicals on the
heart development of zebrafish embryos, we previously
treated zebrafish embryos with chemicals from a Sigma
LOPAC1280™ library and found several chemicals
including b-lapachone that affected heart morphogen-
esis. In this study, we further evaluated the effects of b-
lapachone on zebrafish embryonic heart development.
We detected reduced fractional shortening, defects in
heart-looping and valve development in b-lapachone-
treated embryos. DNA fragmentation was also detected
in both erythrocytes and the endocardium of b-lapa-
chone-treated embryos. Furthermore, we demonstrated
that the induction of apoptosis of the endocardium and
erythrocytes by b-lapachone is mediated through an
NQO1- and calcium-dependent pathway. This study, we
believe, further demonstrates the importance of the
endocardium and hemodynamic forces on heart mor-
phogenesis and contractile performance in zebrafish
embryos as a model system.
Materials and methods
Fish maintenance and collection of embryos
Adult zebrafish (Danio rerio)w e r er a i s e da tt h ez e b r a -
fish facility of the Institute of Cellular and Organismic
Biology, Academia Sinica, Taipei, Taiwan. The fish were
maintained in 20-L aquariums supplied with filtered
fresh water and aeration under a 14-h light: 10-h dark
photoperiod. Different developmental stages were deter-
mined based on previously described morphological cri-
teria [30].
b-Lapachone treatment
Embryos were treated with b-lapachone (Sigma-Aldrich,
St. Louis, MO, USA) at a final concentration of 2 μM
d i l u t e dw i t he g gw a t e ra t2 4o r4 8h p ff o r4ha t2 8 ° C .
Embryos from the same developmental stage treated
with 0.2% DMSO for 4 h were used as the control.
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Whole-mount in situ hybridization was performed on
embryos treated with 0.003% phenylthiocarbamide using
digoxigenin-labeled antisense RNA probes and alkaline
phosphatase-conjugated anti-digoxigenin antibodies as
described previously [31]. Various templates were linear-
ized, and antisense RNA probes were generated as fol-
lows: BMP4 (Not I/T7), cmlc2 (Nco I/SP6), hbae1 (Not
I/T7), nfatc1 (Spe I/T7), nppa (Nco I/SP6), and versican
(Nco I/SP6).
o-Dianisidine (ODA) staining
Embryos were fixed with 4% paraformaldehyde overnight
at 4°C. After several washes with PBST (1 × PBS and
0.1% Tween-20), b-lapachone- and DMSO-treated 48-
hpf embryos were incubated in H2O2 (20 μl/ml)-activated
ODA staining buffer (0.6 mg/ml ODA (Sigma-Aldrich,
S t .L o u i s ,M O ,U S A )i n1 0m Ms o d i u ma c e t a t e( p H5 . 2 )
and 4% ethanol) for 15 min in the dark at room tempera-
ture and then washed with PBST several times.
ROS assay
b-Lapachone- and DMSO-treated embryos were incu-
bated in 5-(and 6-)-chloromethyl-2’,7’-dichloro-dihydro-
fluorescein diacetate (CM-H2DCFDA) (Invitrogen,
Carlsbad, CA, USA) at a final concentration of 500 ng/
ml for 1 h in the dark at room temperature. After rin-
sing with egg water, embryos were examined using
fluorescence microscopy equipped with a green fluores-
cent protein (GFP) filter.
TUNEL assay and histological analysis
For the TUNEL assay to analyze apoptosis in the heart
and erythrocytes, 48-hpf embryos were treated with
either b-lapachone or DMSO for 4 h and then fixed at 52
hpf for ODA staining. Subsequently ODA-stained
DMSO- and b-lapachone-treated 52-hpf embryos were
fixed in 4% paraformaldehyde overnight at 4°C and
embedded in paraffin according to standard procedures.
Paraffin sections (5 μm) were dewaxed and rehydrated in
PBST through an ethanol series. They were treated with
10 μg/ml proteinase K for 15 min at room temperature
before DNA breaks were labeled with terminal deoxynu-
cleotidyl transferase and fluorescein-dUTP according to
protocols provided by the manufacturer (Roche Applied
Bioscience, Mannheim, Germany). Nuclei were stained
with DAPI. For the histological analysis, paraffin section-
ing and hematoxylin (Vector, Burlingame, CA, USA) and
eosin (Muto Pure Chemical, Tokyo, Japan) staining were
performed according to standard procedures.
Dextran rhodamine dye injection and photography
Diluted dextran rhodamine was injected into tail reticular
cells of 48-hpf embryos using an IM300 microinjector
(Narishigi, Tokyo, Japan). Images of embryos from var-
ious analyses were taken using an RT color digital camera
(SPOT, Mchenry, IL, USA) on either a Zeiss Axioplan 2
microscope (Göttingen, Germany) or a Leica Z16 APO
microscope (Wetzlar, Germany) equipped DIC or FITC
mode.
Wall shear stress and fractional shortening (FS)
measurements
For wall shear stress and the FS analyses, 24-hpf Tg
(gata1:DsRed) and 48-hpf AB embryos were treated with
either b-lapachone or DMSO for 4 h, and then their
blood cell circulations and heart pumping were recorded
at 30 and 52 hpf, respectively, via time-lapse fluores-
cence microscopy using an AxioCam HRC camera with
a high-speed recording mode (50 frames/s) under a
Z e i s sA x i oI m a g e rM 1m i c r o s c o p e( G ö t t i n g e n ,G e r -
many) with a tetramethylrhodamine isothiocyanate
(TRITC; corresponding to pseudo-colored red) filter set.
Real-Time Quantitative (Q) Reverse-Transcription (RT)-PCR
Q-RT-PCR was conducted and analyzed as described
[32]. The primer pair for nppa was F-GGCAACAGAA-
GAGGCATCAGAG and R-GGAGCTGCTGCTTC
CTCTCGGTC. The primer pair for b-actin was F-
CCATTGGCAATGAGAGGTTCAG and R-TGAT
GGAGTTGAAAGTGGTCTCG.
Results
Phenotypes of b-lapachone-treated embryos
Embryos at 6 hpf were first treated with different con-
centrations (2, 5, 10, and 50 μM) of b-lapachone over-
night; then the death of embryos was observed in all
treatments (data not shown). Subsequently, 24-hpf
embryos were treated with 2 μM b-lapachone for differ-
ent time periods to evaluate its effect on heart develop-
ment (data not shown). We then treated 24-hpf
embryos with 2 μM b-lapachone for 4 h and found that
b-lapachone-treated 30-hpf embryos showed pericardial
edema compared to DMSO-treated embryos (Figure 1A
&1B). Pronounced pericardial edema accompanied by a
linear arrangement of the ventricle and atrium which
underwent bradycardia arrhythmia and the presence of
only a few or no erythrocytes in the blood circulation
were observed in b-lapachone-treated 52- and 72-hpf
embryos (Figure 1C-J). Severe pericardial and yolk
edema accompanied by the linear arrangement of the
heart chambers and a lack of blood circulation were
observed in b-lapachone-treated 96-hpf embryos com-
pared to DMSO-treated embryos (Figure 1K &1L). A
blood circulation defect was further confirmed by inject-
ing dextran rhodamine into both b-lapachone- and
DMSO-treated 48-hpf embryos. The injected dextran
rhodamine dye was readily observed in all vasculature of
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in b-lapachone-treated embryos, the dye remained in
the yolk extension region close to the injection point for
at least 16 min (Figure 1M-P).
Defects in heart-looping and valve development and
decreased cardiac output were recorded in b-lapachone-
treated embryos
To clarify the role of b-lapachone treatment in heart
chamber morphogenesis, we treated 24-hpf embryos
with either DMSO or b-lapachone for 4 h and then
fixed them at 48 and 72 hpf for whole-mount in situ
hybridization using nppa and cmlc2 as RNA probes. In
DMSO-treated 48- and 72-hpf embryos, nppa expres-
sion was restricted to the outer curvature of the ventri-
cle and atrium [10], whereas nppa was intensively
expressed in the entire ventricle and atrium in b-lapa-
chone-treated 48-hpf embryos (n > 50), and decreased
nppa expression was later shown in b-lapachone-treated
72-hpf embryos (n > 50) (Figure 2A). Quantitative real
time-RT-PCR analyses of the nppa expression level
further confirmed the whole-mount in situ hybridization
results (panel i in Figure 2A). In DMSO-treated 48- and
72-hpf embryos, cmlc2 was mainly expressed in looped
ventricle and to some extent in the atrium, While, simi-
lar level of cmlc2 expression in the linearly arranged
atrium and ventricle was found in b-lapachone-treated
48- and 72-hpf embryos (n > 50) (Figure 2A).
Furthermore, in order to evaluate the influence of b-
lapachone treatment on cardiac output, we treated 48-
hpf embryos with either DMSO or b-lapachone for 4 h
and then recorded their heart pumping at 52 hpf (panel
Figure 1 Phenotype and circulation defect of b-lapachone-treated embryos. Embryos at 24 hours post-fertilization (hpf) were treated with
DMSO or b-lapachone for 4 h and examined at 30 (A, B), 52 (C-F), 72 (G-J), and 96 hpf (K, L). Dextran rhodamine dye-injected and DMSO-treated
48-hpf embryos 2 min after dye injection (M, N), and dextran rhodamine dye-injected b-lapachone-treated 48-hpf embryos 2 min (O) and 16
min after dye injection (P) are shown. Arrowheads indicate erythrocytes. The star indicates yolk edema. Black arrows point to the linear
arrangement of the heart chambers and pericardial edema, while white arrows in panels N-P indicate dye injection sites. Scale bars represent
100 μm.
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Page 4 of 13Figure 2 Defects in heart-looping, valve formation, and contractile performance were detected in b-lapachone-treated embryos.A :
Embryos at 24 hours post-fertilization (hpf) were treated with DMSO or b-lapachone for 4 h and fixed at 48 and 72 hpf for nppa and cmlc2
hybridization (a-h). A Q-RT-PCR analysis indicated nppa expression levels in b-lapachone-treated 48- and 72-hpf embryos (i). B: Images of
respective hearts with ventricles at either end-diastolic volume of DMSO (a), b-lapachone-treated embryo containing few erythrocytes (b), and b-
lapachone-treated embryo containing no erythrocytes (c), or at end-systolic volume of DMSO (a’), b-lapachone-treated embryo containing few
erythrocytes (b’), and b-lapachone-treated embryo containing no erythrocytes (c’) are shown. Fractional shortening (FS) of the atrial and
ventricular chamber of DMSO or b-lapachone-treated 52-hpf embryos was measured and calculated according to the formula, FS = (ED - ES)/ED
× 100%, where ED is the end-diastolic diameter and ES is the end-systolic diameter of either the atrial or ventricular chambers (d). In b-
lapachone-treated embryos, embryos containing few or no erythrocytes were recorded. Error bars indicate the standard error. Student’s t-test
was used to compare DMSO- and b-lapachone-treated embryos. * p < 0.001. C: DMSO- and b-lapachone-treated 48- and 72-hpf embryos were
fixed for bmp4, versican, and nfatc1 hybridization. D: Paraffin sectioning and H&E staining of hearts of respective DMSO- and b-lapachone-treated
72- and 96-hpf embryos are shown. Arrows indicate the positions of the cardiac cushion (a) and valve (b). A, atrium; V, ventricle; VB,
ventriculobulbal junction; AV, atrioventricular junction. Scale bars represent 100 μm.
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embryos into either embryos containing few erythro-
cytes (n =6 )o rn oe r y t h r o c y t e s( n = 8). We found that
the fractional shortening (FS) of both the atrium and
ventricle was significantly decreased in both groups of
b-lapachone-treated 52-hpf embryos compared to
DMSO-treated embryos (n = 9) (panel d in Figure 2B).
During heart valve development, BMP signals from
the myocardium promote the endocardial cushion to
undergo the epithelial-mesenchymal transition [33,34].
Nfatc1 expression in the endocardial cushion is essential
for its growth and subsequent valve remodeling [33].
Versican is an extracellular matrix component in the
heart that is required for the development of endocar-
dial cushion swelling [35]. Therefore, we selected BMP4,
versican,a n dnfatc1 as RNA probes for whole-mount in
situ hybridization to investigate heart valve development
of zebrafish embryos treated with b-lapachone. We trea-
ted 24-hpf embryos with either DMSO or b-lapachone
for 4 h and then fixed them at 48 and 72 hpf to perform
whole-mount in situ hybridization. In DMSO-treated
48-hpf embryos, BMP4 was expressed in the myocar-
dium located at the ventriculobulbal (VB) and atrioven-
tricular (AV) junctions, whereas both versican and
nfatc1 were mainly respectively expressed in the myo-
c a r d i u ma n de n d o c a r d i u ma tt h eA Vj u n c t i o no ft h e
heart in both DMSO-treated 48- and 72-hpf embryos
(Figure 2C). Ectopic expressions of BMP4 (n > 50), ver-
sican (n >5 0 ) ,a n dnfatc1 (n > 50) in both the ventricle
and atrium were observed in b-lapachone-treated 48-
and 72-hpf embryos compared to DMSO-treated control
embryos (Figure 2C). Histological analyses further
demonstrated the respective impairment of endocardial
cushion formation and valve development in b-lapa-
chone-treated 72- (N =4 ,n = 20) and 96-hpf (N =4 ,n
= 20) embryos (Figure 2D). These results indicate that
heart morphogenesis including heart-looping, formation
of the heart chamber curvature and valve, and cardiac
output were affected by b-lapachone treatment.
b-Lapachone treatment induces the death of erythrocytes
and endocardium
Embryos at 24 hpf were treated with either DMSO or b-
lapachone for 4 h and then fixed at 30 and 48 hpf to
analyze the presence of erythrocytes by whole-mount in
situ hybridization using hbae1 (hemoglobin a embryonic
1) as a probe and hemoglobin staining with ODA (Fig-
ure 3A). In DMSO-treated 30- and 48-hpf embryos,
hbae1-hybridized erythrocytes were readily observed in
the dorsal aorta, posterior cardinal vein, and common
cardinal vein. Relatively few hbae1-hybridized erythro-
cytes were observed in b-lapachone-treated 30-hpf
embryos (n > 50), and no hbae1 hybridization was
detected in b-lapachone-treated 48-hpf embryos (n >
50) (Figure 3A). Similarly ODA-stained hemoglobin was
readily observed in both the dorsal aorta and posterior
cardinal vein of DMSO-treated 48-hpf embryos; how-
ever, no ODA-stained hemoglobin was detected in b-
lapachone-treated embryos (n > 50) (Figure 3A). Quanti-
tative real time-RT-PCR analyses further confirmed the
presence of very low expression levels of both hbae1
and hbbe1 (hemoglobin b embryonic 1)i nb-lapachone-
treated 48-hpf embryos (data not shown).
Since proerythroblasts from the intermediate cell mass
expressing embryonic globins began to enter the circula-
tion at 24 hpf, and hematopoiesis shifted from a primi-
t i v et oad e f i n i t i v ew a v ea ta r o u n d3 0h p f ,w ea l s o
analyzed these two transcriptional factors which are
important for definitive hematopoiesis [36]. Similar
expression patterns and levels of c-myb (n > 50) and
ikaros (n > 50) were found in DMSO- and b-lapachone-
treated 30-hpf embryos, indicating that definitive hema-
topoiesis was not affected by b-lapachone treatment
(Additional file, Fig. S1).
Since the incubation of b-lapachone with Trypano-
soma cruzi preferentially causes the inhibition of DNA
synthesis and DNA damage from the generation of oxy-
gen radicals [15], we also evaluated whether ROS were
generated in b-lapachone-treated embryos [37]. In the
presence of peroxyl radicals (a type of ROS), CM-
H2DCFDA is converted to the fluorescent dichlorofluor-
escein (DCF). We treated 24-hpf embryos with either
DMSO or b-lapachone for 4 h and then incubated them
with CM-H2DCFDA for 1 h at 29 hpf. Erythrocytes with
green fluorescence were detected flowing from the com-
mon cardinal vein to the atrium of b-lapachone-treated
30-hpf embryos (N =4 ,n > 50) but not in the respective
DMSO-treated control embryos (Figure 3B).
Unlike mammals, zebrafish erythrocytes possess
nuclei. Therefore, we treated 48-hpf embryos with either
DMSO or b-lapachone for 4 h and fixed them at 52 hpf
for ODA staining. These ODA-stained embryos were
then used for the TUNEL assay. In DMSO-treated con-
trol embryos, a group of ODA-stained erythrocytes were
detected in the tail blood island but fail to be labeled by
fluorescein-dUTP (panel a-d in Figure 3C). In contrast,
fluorescein-dUTP-labeled erythrocytes were found close
to several ODA-stained erythrocytes in the tail blood
island of b-lapachone-treated 52-hpf embryos (panel e-h
in Figure 3C; N =3 ,n = 15). However, ODA-stained
erythrocytes did not show DNA fragmentation, indicat-
ing that fluorescein-dUTP-labeled erythrocytes had
already lost their hemoglobin in the cytoplasm.
Although we did not detect ROS in the hearts of b-
lapachone-treated 30-hpf embryos incubated with CM-
H2DCFDA, TUNEL staining of paraffin sections
revealed the presence of fluorescein-dUTP-labeled cells
in the endocardium of the atrium and ventricle of b-
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Page 6 of 13Figure 3 Induction of ROS and DNA fragmentation in erythrocytes and the endocardium by b-lapachone treatment.A :E m b r y o sa t2 4
hours post-fertilization (hpf) were treated with DMSO or b-lapachone for 4 h and fixed at 30 and 48 hpf for either hbae1 hybridization or o-
dianisidine (ODA) staining. B: DMSO- and b-lapachone-treated embryos were incubated with CM-H2DCFDA for 1 h at 29 hpf, and both bright-
field (a, c) and fluorescent (b, d-f) images under a green fluorescent protein (GFP) filter were recorded. Atrial boundary is depicted by white
dotted lines. Arrows indicate flowing erythrocytes with green fluorescence from the common cardinal vein to the atrium of the heart (d-f) of b-
lapachone-treated embryos. C: Embryos were treated with DMSO or b-lapachone at 48 hpf for 4 h, fixed at 52 hpf, and stained with ODA. After
paraffin sectioning, TUNEL reactions were conducted, and fluorescein-dUTP-labeled erythrocytes were detected in b-lapachone-treated embryos
(f, h). DIC images are shown (a, e), and the inset figure in panel a shows the position of sectioning. Tail border is illustrated by white dotted
lines. Arrows in panels a and e indicate ODA-stained erythrocytes. D: Embryos were treated with DMSO or b-lapachone at 48 hpf for 4 h and
fixed at 52 hpf. After paraffin sectioning, TUNEL reactions were conducted, and fluorescein-dUTP-labeled cells located in the endocardium were
detected in b-lapachone-treated embryos (f, h, j, l). In addition, fluorescein-dUTP-labeled erythrocytes were detected in the yolk near the heart (f,
j). Red dotted lines indicate borders of head and yolk while white dotted lines illustrate ventricle boundaries. * indicates erythrocytes. V, ventricle.
Scale bars represent 100 μm.
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not in DMSO-treated control embryos (Figure 3D). In
addition, fluorescein-dUTP-labeled erythrocytes were
observed in the yolk near the heart probably in the
common cardinal vein (panels f & j in Figure 3D).
These results indicated that b-lapachone treatment
caused the occurrence of ROS in erythrocytes and DNA
fragmentation in the endocardium and erythrocytes of
zebrafish embryos.
Decreased wall shear stress was identified in b-
lapachone-treated embryos
Both the velocity gradient and blood viscosity when
blood flows in a blood vessel are major physical factors
determining the fluidic shear stress, and one of the major
factors influencing the blood viscosity is hematocrit
[38,39]. Since we observed a decreased number of ery-
throcytes in b-lapachone-treated embryos, we then evalu-
ated the effect of b-lapachone treatment on the wall
shear stress in the caudal artery of embryos. We treated
24-hpf Tg(gata1:DsRed)e m b r y o sw i t hb-lapachone for 4
h and recorded the blood cell circulation at 30 hpf. Here,
we used the formula 4 μQ/πR
3 to determine the wall
shear stress, where μ is viscosity, Q is the flow rate, and R
is the blood vessel diameter [7]. We first measured the
average diameter of the caudal artery in DMSO- (20 μm)
and b-lapachone-treated embryos (17 μm) and obtained
the velocity of several individual DsRed-labeled erythro-
cyte in the caudal artery of DMSO- and b-lapachone-
treated embryos by tracing the distance they traveled in a
fixed period of time via time-lapse fluorescence micro-
scopy. Flow rate (Q) was then calculated based on the
average diameter of the caudal artery and average velocity
of erythrocytes in both DMSO- (0.000533 μm/s) and b-
lapachone-treated (0.000329 μm/s) embryos. We then
estimated the relative shear stress using the viscosity
value (0.008 Nt·s/m
2) measured in oxygenated trout can-
nula blood at 26% hematocrit and a 90/s shear rate [40].
As shown in Figure 4, the wall shear stress (τ)s i g n i f i -
cantly decreased in b-lapachone-treated (1.24 Nt/m
2) 30-
hpf embryos (n = 14) compared to DMSO-treated (1.55
Nt/m
2) control embryos (n = 10).
Figure 4 Decreased wall shear stress was detected in b-lapachone-treated embryos.T g ( gata1:DsRed) was treated with DMSO or b-
lapachone for 4 h at 24 h post-fertilization (hpf), and blood cell circulation was recorded at 30 hpf. A: A DIC image of 30-hpf embryos is shown.
The inset figure in panel A indicates the recorded region, and DsRed-labeled erythrocytes were recorded under the TRITC mode (a-f). Images
corresponding to an individual DsRed-labeled erythrocyte (arrow) at time 0 and after traveling for some distance at time t are shown for
respective DMSO-treated (a, b) and 2 representative b-lapachone-treated (c, d; e, f) embryos. B: The relative wall shear stress was calculated
based on τ =4μQ/πR
3 where μ is viscosity, Q is the flow rate, and R is the blood vessel diameter. Student’s t-test was used to compare DMSO-
and b-lapachone-treated embryos. * p < 0.01.
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lapachone rescued both the heart-looping defect and
erythrocyte-deficiency in circulation phenotypes
Since b-lapachone treatment induces NQO1- and μ-cal-
pain-mediated apoptosis in a number of tumors [26,27],
we evaluated whether the erythrocyte-deficiency in cir-
culation and heart-looping defect phenotypes in zebra-
fish embryos induced by b-lapachone also adopted a
similar mechanism. Dicoumarol, an inhibitor of NQO1,
and BAPTA-AM, a Ca
2+ ion chelator which can affect
the activity of calcium-dependent μ-calpain, were used
[41,24]. We treated 24-hpf embryos with either 2 μM b-
lapachone (n = 318 and 627) alone or together with
either 5 μMd i c o u m a r o l( n = 215) or 50 μMB A P T A -
AM (n = 557) for 4 h and fixed them at 48 hpf. In b-
lapachone-treated 48-hpf embryos, a linear arrangement
of the ventricle and atrium, ectopic nppa expression,
and no ODA-stained erythrocytes were observed com-
pared to DMSO- (n = 243) and dicoumarol-treated (n =
193) control embryos (Figure 5A-F). However, approxi-
mately 76% of 48-hpf embryos treated with both b-lapa-
chone and dicoumarol showed levels of ODA-stained
erythrocytes in circulation and a normal heart chamber
morphology as assayed by nppa expression patterns,
compared to those of control embryos (Figure 5G-I).
Similarly, co-treatment with BAPTA-AM also rescued
the b-lapachone-induced heart-looping defect and ery-
throcyte-deficiency in circulation phenotypes (data not
shown). Approximately 81% of 48-hpf embryos treated
with both b-lapachone and BAPTA-AM exhibited levels
of ODA-stained erythrocytes in circulation and a normal
heart chamber morphology, compared to DMSO- (n =
216) and BAPTA-AM-treated (n = 239) control embryos
(Figure 5J). Collectively, these results indicate that the
heart-looping defect and erythrocyte-deficiency in circu-
lation phenotypes observed in b-lapachone-treated
embryos were both induced by an NQO1- and calcium-
mediated pathway.
Discussion
b-Lapachone is currently in phase II clinical trials for
treating pancreatic adenocarcinomas due to its antitu-
mor activity [42]. It was also shown to have potential
therapeutic use due to its wound healing-promoting
activity [43]. In our study, we evaluated the potential
effects of b-lapachone on heart development using zeb-
rafish as the model organism.
b-Lapachone treatment induces apoptosis of the
endocardium and erythrocytes which in turn affect heart
morphogenetic development and function
We observed a linear arrangement of the ventricle and
atrium, bradycardia arrhythmia, reduced FS, and circula-
tion with only a few or no blood cells in b-lapachone-
treated 48-hpf embryos (Figure 1). Abnormal expression
patterns of cmlc2, nappa, BMP4, versican,a n dnfatc1
and histological analyses demonstrated that there were
defects in heart-looping and valve development in b-
lapachone-treated embryos (Figure 2). Furthermore, we
detected the presence of ROS in erythrocytes and DNA
fragmentation in both the endocardium and erythrocytes
of b-lapachone-treated embryos (Figure 3). These results
indicate that defects in heart morphogenetic develop-
ment and function can be attributed to apoptosis of the
endocardium and erythrocytes induced by b-lapachone
treatment.
An integral endocardium is essential for cardiac
valve development because it gives rise to the endo-
cardial cushion through an epithelial-to-mesenchymal
transition process [33]. In addition, integral cardiac
endocardial and myocardial interaction is required for
proper heart development and contractile function
[44]. Neuregulin-1 is a paracrine factor produced by
endocardium endothelial cells. Mice possessing a
homozygous mutation in Neuregulin-1 showed a heart
that lacked trabecular formation in the ventricular
wall, and slower contractions of the atrium and ventri-
cle [45]. Similarly, Neuregulin/ErbB signaling was
shown to be essential for ventricle trabeculation in
zebrafish embryos, and knockdown Neuregulin-1
expression in zebrafish also resulted in heart develop-
ment defects especially in the conducting system
[46,47]. Therefore, our results further demonstrate the
importance of the endocardium in cardiac structural
and functional development.
As hematocrit influences the blood viscosity, which is
one of the main physical factors affecting blood fluidic
shear stress on the blood vessel wall [7,39], our relative
wall shear stress approach also indicated a significant
decrease in the wall shear stress in b-lapachone-treated
embryos due to relatively few erythrocytes in the circu-
lation (Figure 4). A decreased wall shear stress produced
decreased hemodynamic forces which further impacted
heart development and function in b-lapachone-treated
embryos.
Both the endothelium and erythrocytes are regulated by
oxidative stress
Oxidative stress was shown to regulate the growth, sur-
vival, and apoptosis of vascular smooth muscle and
endothelial cells [48]. Cytokines and growth factors (e.g.,
tumor necrosis factor-a, interleukin 1b, and angiotensin
II) were shown to promote the generation of superoxide
in endothelial cells by activating NADPH oxidase
[49,50]. ROS then cause the release of cytochrome C
from mitochondria to activate caspase, resulting in
phosphatidylserine exposure, DNA fragmentation, and
cell morphological changes [51]. A study on human
Wu et al. Journal of Biomedical Science 2011, 18:70
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Page 9 of 13umbilical vein endothelial cells further demonstrated
that the activities of both caspase 3 and c-Jun N-term-
inal kinases (JNKs) were stimulated due to an increase
in intracellular ROS levels [52].
The function and fate of erythrocytes are under redox
control [53]. Although the presence of a high iron con-
centration, hemoglobin, and both non-enzymatic and
enzymatic antioxidants provide erythrocytes with an
Figure 5 Both dicoumarol and BAPTA-AM rescued the erythrocyte-deficiency in circulation and heart-looping defect phenotypes in b-
lapachone-treated embryos. Embryos at 24 hours post-fertilization (hpf) were treated with either 0.2% DMSO (A, B), 5 μM dicoumarol (C, D), 2
μM b-lapachone (E, F), or 2 μM b-lapachone and 5 μM dicoumarol (G, H) for 4 h and fixed for nppa hybridization and o-dianisidine (ODA)
staining at 48 hpf. Higher-magnification ODA-stained images of the ventral tail region are shown (B, D, F, H). (I, J) Evaluation of the rescue effects
by dicoumarol or BAPTA-AM. Error bars indicate the standard error. Scale bars represent 100 μm.
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Page 10 of 13antioxidant capacity, erythrocytes can become the target
of xenobiotics or ROS produced by nearby tissues, thus
accumulating oxidative damage and then being removed.
Several components of the apoptotic machinery found
in nucleated cells were identified to be upregulated in
mammalian erythrocytes under oxidative stress. Procas-
pase 3 was found in mature human erythrocytes and is
activated under oxidative stress upon t-butylhydroperox-
ide treatment leading to impairment of aminophospholi-
pid flippase activity, phosphatidylserine externalization,
and increased erythrophagocytosis [54]. Components of
the extrinsic apoptotic pathway including FasL, the Fas-
associated death domain, and caspase 8 were shown to
form complexes in membrane rafts of aged and oxida-
tively stressed erythrocytes. A previous study also
showed that oxidative stress can activate Ca
2+-perme-
able cation channels, cause increased cytosolic calcium
concentrations, and trigger erythrocyte apoptosis [55].
Induction of cell death of erythrocytes and the
endocardium in zebrafish embryos by b-lapachone is
mediated through an NQO1- and calcium-dependent
pathway
The linear arrangement of the ventricle and atrium and
the presence of only a few or no erythrocytes in circulation
were observed in b-lapachone-treated 52-, 72-, and 96-hpf
embryos (Figure 1). In addition, b-lapachone treatment
caused the occurrence of ROS in erythrocytes and DNA
fragmentation in erythrocytes and the endocardium of
zebrafish embryos (Figure 3). In a number of tumors
which possess high expression levels of NQO1, b-lapa-
chone can be reduced by NQO1 and leads to a futile cycle
between quinone and hydroquinone, accompanied by
depletion of NAD(P)H and the generation of ROS. ROS
can cause DNA damage, hyperactivation of PARP-1,
which depletes NAD
+ a n dA T Pp o o l st h a tr e s u l t si n
increased intracellular cytosolic Ca
2+ concentrations, and
the activation of μ-calpain cysteine protease activity
[23-25]. We also showed that both the heart-looping
defect and erythrocyte-deficiency in circulation pheno-
types could be rescued by co-incubation of b-lapachone
with either dicoumarol, an NQO1 inhibitor, or BAPTA-
AM, a Ca
2+ chelator (Figure 5). These results indicate that
the induction of cell death of erythrocytes and the endo-
cardium in zebrafish embryos by b-lapachone is mediated
through an NQO1- and calcium-dependent pathway.
A recent study also showed that oral treatment of rats
with b-lapachone induced anemia that was attributed to
increased phosphatidylserine externalization and ery-
throphagocytosis induced by ROS [56]. However, the
extents of reduction in erythrocyte cell numbers in adult
rats (22%~26%) and zebrafish embryos (75%~90%) upon
b-lapachone treatment greatly differed. This discrepancy
may have been due to the presence of mitochondria in
mature fish erythrocytes but not in mature mammalian
erythrocytes [57]. It was shown that over 60 moles of
NAD(P)H are used by NQO1 to react with each mole of
b-lapachone. Since the citric acid cycle in mitochondria
can produce more NADH than glycolysis in the cytosol,
we suggest that more ROS can be generated in zebrafish
erythrocytes than in rat erythrocytes upon b-lapachone
treatment. ROS then cause DNA damage, an increased
cytosolic Ca
2+ concentration either from endoplasmic
reticulum release or entry from Ca
2+-permeable cation
channels, loss of ATP and NAD
+, and inhibition of
DNA repair, leading to cell death [23].
Conclusions
Our study indicates that b-lapachone treatment causes
death of the endocardium and erythrocytes in zebrafish
embryos resulting in defects in heart-looping, valve for-
mation, and cardiac output. The induction of apoptosis
of the endocardium and erythrocytes by b-lapachone is
mediated through an NQO1- and calcium-dependent
pathway. This study further demonstrated the impor-
tance of the endocardium and hemodynamic forces to
heart morphogenesis and contractile performance.
Additional material
Additional file 1: Figure S1 Effects of b-lapachone treatment on the
expressions of c-myb and ikaros. Embryos were treated with DMSO or
b-lapachone at 24 hours post-fertilization (hpf) for 4 h and fixed at 30
hpf for whole-mount in situ hybridization using either c-myb (A, B) or
ikaros (C, D) as RNA probes. Scale bars represent 100 μm.
List of abbreviations used
hpf: hours post fertilization; DMSO: dimethyl sulfoxide; ODA: o-Dianisidine;
NQO1: NAD(P)H:quinone oxidoreductase; PARP-1: poly(ADP-ribose)
polymerase-1; FS: fractional shortening; VB: ventriculobulbal; AV:
atrioventricular; DIC: differential interference contrast; TRITC:
tetramethylrhodamine isothiocyanate
Acknowledgements
This study was supported by grants from Academia Sinica (# 94M011 and
AS-99-TP-B08) to SPLH. We would like to thank Dr. Han-Jia Lin, Dr. Chin-Hwa
Hu, and Dr. Yi-Chuan Cheng for their helpful discussions and advice. The
authors thank Ms. Wun-Hsiang Yu for her maintenance of the fish room. We
thank the Core Facility of the Institute of Cellular and Organismic Biology,
Academia Sinica, for assistance with DNA sequencing. We thank Taiwan
Zebrafish Core at Academia Sinica (ZCAS), funded by the National Science
Council (NSC 100-2321-B-001-030) for providing Tg(gata1:DsRed) transgenic
fish.
Author details
1Institute of Bioscience and Biotechnology, National Taiwan Ocean
University, Keelung, Taiwan.
2Graduate Institute of Life Sciences, National
Defense Medical Center, National Defense University, Neihu, Taipei, Taiwan.
3Institute of Cellular and Organismic Biology, Academia Sinica, Taipei, Taiwan.
4Institute of Biological Chemistry, Academia Sinica, Taipei, Taiwan.
5Institute
of Nanoengineering and Microsystems, National Tsing Hua University,
Hsinchu, Taiwan.
Wu et al. Journal of Biomedical Science 2011, 18:70
http://www.jbiomedsci.com/content/18/1/70
Page 11 of 13Authors’ contributions
YTW conducted the drug treatment, whole-mount in situ hybridization,
histological sectioning, TUNEL assay, and interpretation of data. LCY
participated in the ROS, fractional shortening, rhodamine dye injection, and
wall shear stress measurement. MYT carried out the whole-mount in situ
hybridization and interpretation of data. YHC participated in the initial drug
screening and histological sectioning. YFL carried out the histological
sectioning and TUNEL assay. CJH participated in the contribution of reagents
and interpretation of data. CMC participated in the interpretation of data
and helped to draft the manuscript. SPLH participated in the design of this
study, performed statistical analysis, interpretation of data and draft the
manuscript. All authors read and approved the final manuscript.
Competing interests
The authors declare that they have no competing interests.
Received: 24 May 2011 Accepted: 22 September 2011
Published: 22 September 2011
References
1. Stainier DY: Zebrafish genetics and vertebrate heart formation. Nat Rev
Genet 2001, 2:39-48.
2. Bartman T, Walsh EC, Wen KK, McKane M, Ren J, Alexander J,
Rubenstein PA, Stainier DY: Early myocardial function affects endocardial
cushion development in zebrafish. PLoS Biol 2004, 2:E129.
3. Stainier DY, Weinstein BM, Detrich HW, Zon LI, Fishman MC: Cloche, an
early acting zebrafish gene, is required by both the endothelial and
hematopoietic lineages. Development 1995, 121:3141-3150.
4. Pelster B, Burggren WW: Disruption of hemoglobin oxygen transport
does not impact oxygen-dependent physiological processes in
developing embryos of zebra fish (Danio rerio). Circ Res 1996, 79:358-362.
5. Yelon D: Cardiac patterning and morphogenesis in zebrafish. Dev Dyn
2001, 222:552-563.
6. Bruneau BG: Transcriptional regulation of vertebrate cardiac
morphogenesis. Circ Res 2002, 90:509-519.
7. Hierck BP, Van der Heiden K, Poelma C, Westerweel J, Poelmann RE: Fluid
shear stress and inner curvature remodeling of the embryonic heart.
Choosing the right lane! ScientificWorldJournal 2008, 8:212-222.
8. Hove JR, Koster RW, Forouhar AS, Acevedo-Bolton G, Fraser SE, Gharib M:
Intracardiac fluid forces are an essential epigenetic factor for embryonic
cardiogenesis. Nature 2003, 421:172-177.
9. Jones EA, le Noble F, Eichmann A: What determines blood vessel
structure? Genetic prespecification vs. hemodynamics. Physiology
(Bethesda) 2006, 21:388-395.
10. Auman HJ, Coleman H, Riley HE, Olale F, Tsai HJ, Yelon D: Functional
modulation of cardiac form through regionally confined cell shape
changes. PLoS Biol 2007, 5:e53.
11. Berdougo E, Coleman H, Lee DH, Stainier DY, Yelon D: Mutation of weak
atrium/atrial myosin heavy chain disrupts atrial function and influences
ventricular morphogenesis in zebrafish. Development 2003, 130:6121-6129.
12. Huang C, Sheikh F, Hollander M, Cai C, Becker D, Chu PH, Evans S Chen J:
Embryonic atrial function is essential for mouse embryogenesis, cardiac
morphogenesis and angiogenesis. Development 2003, 130:6111-6119.
13. Schaffner-Sabba K, Schmidt-Ruppin KH, Wehrli W, Schuerch AR, Wasley JW:
beta-Lapachone: synthesis of derivatives and activities in tumor models.
J Med Chem 1984, 27:990-994.
14. Don MJ, Chang YH, Chen KK, Ho LK, Chau YP: Induction of CDK inhibitors
(p21(WAF1) and p27(Kip1)) and Bak in the beta-lapachone-induced
apoptosis of human prostate cancer cells. Mol Pharmacol 2001, 59:784-794.
15. Goijman SG, Stoppani AO: Effects of beta-lapachone, a peroxide-
generating quinone, on macromolecule synthesis and degradation in
Trypanosoma cruzi. Arch Biochem Biophys 1985, 240:273-280.
16. Guiraud P, Steiman R, Campos-Takaki GM, Seigle-Murandi F, Simeon de
Buochberg M: Comparison of antibacterial and antifungal activities of
lapachol and beta-lapachone. Planta Med 1994, 60:373-374.
17. Li YZ, Li CJ, Pinto AV, Pardee AB: Release of mitochondrial cytochrome C
in both apoptosis and necrosis induced by beta-lapachone in human
carcinoma cells. Mol Med 1999, 5:232-239.
18. Schuerch AR, Wehrli W: beta-Lapachone, an inhibitor of oncornavirus
reverse transcriptase and eukaryotic DNA polymerase-alpha. Inhibitory
effect, thiol dependence and specificity. Eur J Biochem 1978, 84:197-205.
19. Logsdon CD, Simeone DM, Binkley C, Arumugam T, Greenson JK, Giordano TJ,
Misek DE, Kuick R, Hanash S: Molecular profiling of pancreatic
adenocarcinoma and chronic pancreatitis identifies multiple genes
differentially regulated in pancreatic cancer. Cancer Res 2003, 63:2649-2657.
20. Malkinson AM, Siegel D, Forrest GL, Gazdar AF, Oie HK, Chan DC, Bunn PA,
Mabry M, Dykes DJ, Harrison SD, et al: Elevated DT-diaphorase activity and
messenger RNA content in human non-small cell lung carcinoma:
relationship to the response of lung tumor xenografts to mitomycin Cl.
Cancer Res 1992, 52:4752-4757.
21. Pink JJ, Planchon SM, Tagliarino C, Varnes ME, Siegel D, Boothman DA: NAD
(P)H:Quinone oxidoreductase activity is the principal determinant of
beta-lapachone cytotoxicity. J Biol Chem 2000, 275:5416-5424.
22. Ross D, Siegel D: NAD(P)H:quinone oxidoreductase 1 (NQO1, DT-
diaphorase), functions and pharmacogenetics. Methods Enzymol 2004,
382:115-144.
23. Bey EA, Wuerzberger-Davis SM, Pink JJ, Yang CR, Araki S, Reinicke KE,
Bentle MS, Dong Y, Cataldo E, Criswell TL, Wagner MW, Li L, Gao J,
Boothman DA: Mornings with Art, lessons learned: feedback regulation,
restriction threshold biology, and redundancy govern molecular stress
responses. J Cell Physiol 2006, 209:604-610.
24. Tagliarino C, Pink JJ, Dubyak GR, Nieminen AL, Boothman DA: Calcium is a
key signaling molecule in beta-lapachone-mediated cell death. J Biol
Chem 2001, 276:19150-19159.
25. Tagliarino C, Pink JJ, Reinicke KE, Simmers SM, Wuerzberger-Davis SM,
Boothman DA: Mu-calpain activation in beta-lapachone-mediated
apoptosis. Cancer Biol Ther 2003, 2:141-152.
26. Ough M, Lewis A, Bey EA, Gao J, Ritchie JM, Bornmann W, Boothman DA,
Oberley LW, Cullen JJ: Efficacy of beta-lapachone in pancreatic cancer
treatment: exploiting the novel, therapeutic target NQO1. Cancer Biol
Ther 2005, 4:95-102.
27. Pardee AB, Li YZ, Li CJ: Cancer therapy with beta-lapachone. Curr Cancer
Drug Targets 2002, 2:227-242.
28. Goldsmith P: Zebrafish as a pharmacological tool: the how, why and
when. Curr Opin Pharmacol 2004, 4:504-512.
29. MacRae CA, Peterson RT: Zebrafish-based small molecule discovery. Chem
Biol 2003, 10:901-908.
30. Kimmel CB, Ballard WW, Kimmel SR, Ullmann B, Schilling TF: Stages of
embryonic development of the zebrafish. Dev Dyn 1995, 203:253-310.
31. Peng MY, Wen HJ, Shih LJ, Kuo CM, Hwang SPL: Myosin heavy chain
expression in cranial, pectoral fin, and tail muscle regions of zebrafish
embryos. Mol Reprod Dev 2002, 63:422-429.
32. Chen YH, Lu YF, Ko TY, Tsai MY, Lin CY, Lin CC, Hwang SPL: Zebrafidh
cdx1b regulates differentiation of various intestinal cell lineages. Dev
Dyn 2009, 238:1021-1032.
33. Combs MD, Yutzey KE: Heart valve development: regulatory networks in
development and disease. Circ Res 2009, 105:408-421.
34. Ma L, Lu MF, Schwartz RJ, Martin JF: Bmp2 is essential for cardiac cushion
epithelial-mesenchymal transition and myocardial patterning.
Development 2005, 132:5601-5611.
35. Mjaatvedt CH, Yamamura H, Capehart AA, Turner D, Markwald RR: The
Cspg2 gene, disrupted in the hdf mutant, is required for right cardiac
chamber and endocardial cushion formation. Dev Biol 1998, 202:56-66.
36. Hsia N, Zon LI: Transcriptional regulation of hematopoietic stem cell
development in zebrafish. Exp Hematol 2005, 33:1007-1014.
37. Hermann AC, Millard PJ, Blake SL, Kim CH: Development of a respiratory
burst assay using zebrafish kidneys and embryos. J Immunol Methods
2004, 292:119-129.
38. Lipowsky HH, Usami S, Chien S: In vivo measurements of “apparent
viscosity” and microvessel hematocrit in the mesentery of the cat.
Microvasc Res 1980, 19:297-319.
39. Papaioannou TG, Stefanadis C: Vascular wall shear stress: basic principles
and methods. Hellenic J Cardiol 2005, 46:9-15.
40. Sorensen B, Weber RE: Effects of oxygenation and the stress hormones
adrenaline and cortisol on the viscosity of blood from the trout
oncorhynchus mykiss. J Exp Biol 1995, 198:953-959.
41. Planchon SM, Wuerzberger S, Frydman B, Witiak DT, Hutson P, Church DR,
Wilding G, Boothman DA: Beta-lapachone-mediated apoptosis in human
promyelocytic leukemia (HL-60) and human prostate cancer cells: a p53-
independent response. Cancer Res 1995, 55:3706-3711.
42. Bey EA, Bentle MS, Reinicke KE, Dong Y, Yang CR, Girard L, Bornmann WG,
Gao J, Boothman DA: An NQO1- and PARP-1-mediated cell death
Wu et al. Journal of Biomedical Science 2011, 18:70
http://www.jbiomedsci.com/content/18/1/70
Page 12 of 13pathway induced in non-small-cell lung cancer cells by β-lapachone.
Proc Natl Acad Sci USA 2007, 104:11832-11837.
43. Kung HN, Yang MJ, Chang CF, Chau YP, Lu KS: In vitro and in vivo wound
healing-promoting activities of beta-lapachone. Am J Physiol Cell Physiol
2008, 295:C931-943.
44. Brutsaert DL: Cardiac endothelial-myocardial signaling: its role in cardiac
growth, contractile performance, and rhythmicity. Physiol Rev 2003,
83:59-115.
45. Lemke G: Neuregulins in development. Mol Cell Neurosci 1996,
7(4):247-262.
46. Milan DJ, Giokas AC, Serluca FC, Peterson RT, MacRae CA: Notch1b and
neuregulin are required for specification of central cardiac conduction
tissue. Development 2006, 133:1125-1132.
47. Peshkovsky C, Totong R, Yelon D: Dependence of cardiac trabeculation on
neuregulin signaling and blood flow in zebrafish. Dev Dyn 2011,
240:446-456.
48. Irani K: Oxidant signaling in vascular cell growth, death, and survival: a
review of the roles of reactive oxygen species in smooth muscle and
endothelial cell mitogenic and apoptotic signaling. Circ Res 2000,
87:179-183.
49. Kunsch C, Medford RM: Oxidative stress as a regulator of gene
expression in the vasculature. Circ Res 1999, 85:753-766.
50. Deshpande SS, Angkeow P, Huang J, Ozaki M, Irani K: Rac1 inhibits TNF-
alpha-induced endothelial cell apoptosis: dual regulation by reactive
oxygen species. FASEB J 2000, 14:1705-1714.
51. Hampton MB, Orrenius S: Redox regulation of apoptotic cell death in the
immune system. Toxicol Lett 1998, 102-103:355-358.
52. Li AE, Ito H, Kim KS, Takeda K, Yu ZY, Ferrans VJ, Finkel T: A role for
reactive oxygen species in endothelial cell anoikis. Circ Res 1999,
85:304-310.
53. Minetti M, Malorni W: Redox control of red blood cell biology: the red
blood cell as a target and source of prooxidant species. Antioxid Redox
Signal 2006, 8:1165-1169.
54. Mandal D, Moitra PK, Saha S, Basu J: Caspase 3 regulates
phosphatidylserine externalization and phagocytosis of oxidatively
stressed erythrocytes. FEBS Lett 2002, 513:184-188.
55. Lang KS, Duranton C, Poehlmann H, Myssina S, Bauer C, Lang F, Wieder T,
Huber SM: Cation channels trigger apoptotic death of erythrocytes. Cell
Death Differ 2003, 10:249-256.
56. Noh JY, Park JS, Lim KM, Kim KY, Bae ON, Chung SM, Shin S, Chung JH: A
naphthoquinone derivative can induce anemia through
phosphatidylserine exposure mediated erythrophagocytosis. J Pharmacol
Exp Ther 2010, 333:414-420.
57. Moyes CD, Sharma ML, Lyons C, Leary SC, Leon M, Petrie A, Lund SG,
Tufts BL: Origins and consequences of mitochondrial decline in
nucleated erythrocytes. Biochim Biophys Acta 2002, 1591:11-20.
doi:10.1186/1423-0127-18-70
Cite this article as: Wu et al.: b-Lapachone induces heart
morphogenetic and functional defects by promoting the death of
erythrocytes and the endocardium in zebrafish embryos. Journal of
Biomedical Science 2011 18:70.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Wu et al. Journal of Biomedical Science 2011, 18:70
http://www.jbiomedsci.com/content/18/1/70
Page 13 of 13